Long-term prognosis of functional outcome in Multiple Sclerosis: Changes in walking ability and the relationship with gait parameters in patients having MS for 9 years.

Long-term prognosis of functional outcome in Multiple Sclerosis: Changes in walking ability and the relationship with gait parameters in patients having MS for 9 years. - Functional Prognosis in MS: changes in walking ability (FUPRO-MS III)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32032

Enrollment

156

Registered

2008-05-20

Start date

2007-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS Multiple Sclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants of the FuPRO-MS I study. Patients with recent MS were recruited in 1998-2000. This study concerns the 9-year follow-up measures of the inception cohort.

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
In addition to the core set of functional outcome measures and HR-QoL measures of the FuPro-study (needed to answer research question 1) instrumental measures and clinical performance tests of gait, energy consumption, muscle strength, muscle coordination, spasticity, somatosensory signs, visual symptoms, and postural stability will be performed.	—

Countries

Netherlands

Outcome results